vs
Honest Company, Inc.（HNST）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Honest Company, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$88.0M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -26.8%，领先410.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -11.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 1.0%）
诚实公司（The Honest Company, Inc.）是总部位于美国洛杉矶的数字化原生消费品公司，由女演员杰西卡·阿尔芭与克里斯托弗·加维根、布莱恩·李共同创立。2021年该公司销售额达3.19亿美元，截至2022年2月估值约为5.5亿美元。现任首席执行官卡拉·贝尔农是美国上市企业中少有的非裔拉丁裔首席执行官。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HNST vs RIGL — 直观对比
营收规模更大
HNST
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出33.0%
-11.8%
净利率更高
RIGL
高出410.8%
-26.8%
两年增速更快
RIGL
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $88.0M | $69.8M |
| 净利润 | $-23.6M | $268.1M |
| 毛利率 | 15.7% | 91.5% |
| 营业利润率 | -27.5% | 33.2% |
| 净利率 | -26.8% | 384.0% |
| 营收同比 | -11.8% | 21.2% |
| 净利润同比 | -2813.2% | 1769.2% |
| 每股收益（稀释后） | $-0.21 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HNSTRIGL
| Q4 25 | $88.0M | $69.8M | ||
| Q3 25 | $92.6M | $69.5M | ||
| Q2 25 | $93.5M | $101.7M | ||
| Q1 25 | $97.3M | $53.3M | ||
| Q4 24 | $99.8M | $57.6M | ||
| Q3 24 | $99.2M | $55.3M | ||
| Q2 24 | $93.0M | $36.8M | ||
| Q1 24 | $86.2M | $29.5M |
净利润HNSTRIGL
| Q4 25 | $-23.6M | $268.1M | ||
| Q3 25 | $758.0K | $27.9M | ||
| Q2 25 | $3.9M | $59.6M | ||
| Q1 25 | $3.3M | $11.4M | ||
| Q4 24 | $-809.0K | $14.3M | ||
| Q3 24 | $165.0K | $12.4M | ||
| Q2 24 | $-4.1M | $-1.0M | ||
| Q1 24 | $-1.4M | $-8.2M |
毛利率HNSTRIGL
| Q4 25 | 15.7% | 91.5% | ||
| Q3 25 | 37.3% | 93.2% | ||
| Q2 25 | 40.4% | 95.6% | ||
| Q1 25 | 38.7% | 91.7% | ||
| Q4 24 | 38.8% | 89.9% | ||
| Q3 24 | 38.7% | 85.5% | ||
| Q2 24 | 38.3% | 92.4% | ||
| Q1 24 | 37.0% | 93.1% |
营业利润率HNSTRIGL
| Q4 25 | -27.5% | 33.2% | ||
| Q3 25 | 0.3% | 40.9% | ||
| Q2 25 | 3.1% | 60.1% | ||
| Q1 25 | 2.6% | 23.9% | ||
| Q4 24 | -1.0% | 28.9% | ||
| Q3 24 | 0.1% | 25.4% | ||
| Q2 24 | -4.3% | 1.2% | ||
| Q1 24 | -1.5% | -23.6% |
净利率HNSTRIGL
| Q4 25 | -26.8% | 384.0% | ||
| Q3 25 | 0.8% | 40.2% | ||
| Q2 25 | 4.1% | 58.6% | ||
| Q1 25 | 3.3% | 21.5% | ||
| Q4 24 | -0.8% | 24.9% | ||
| Q3 24 | 0.2% | 22.5% | ||
| Q2 24 | -4.4% | -2.8% | ||
| Q1 24 | -1.6% | -27.9% |
每股收益（稀释后）HNSTRIGL
| Q4 25 | $-0.21 | $14.11 | ||
| Q3 25 | $0.01 | $1.46 | ||
| Q2 25 | $0.03 | $3.28 | ||
| Q1 25 | $0.03 | $0.63 | ||
| Q4 24 | $-0.01 | $0.82 | ||
| Q3 24 | $0.00 | $0.70 | ||
| Q2 24 | $-0.04 | $-0.06 | ||
| Q1 24 | $-0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $169.7M | $391.5M |
| 总资产 | $225.4M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HNSTRIGL
| Q4 25 | $89.6M | $155.0M | ||
| Q3 25 | $71.5M | $137.1M | ||
| Q2 25 | $72.1M | $108.4M | ||
| Q1 25 | $72.8M | $77.1M | ||
| Q4 24 | $75.4M | $77.3M | ||
| Q3 24 | $53.4M | $61.1M | ||
| Q2 24 | $36.6M | $49.1M | ||
| Q1 24 | $33.6M | $49.5M |
总债务HNSTRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HNSTRIGL
| Q4 25 | $169.7M | $391.5M | ||
| Q3 25 | $190.2M | $117.6M | ||
| Q2 25 | $187.0M | $81.9M | ||
| Q1 25 | $180.4M | $18.6M | ||
| Q4 24 | $174.3M | $3.3M | ||
| Q3 24 | $133.9M | $-14.6M | ||
| Q2 24 | $129.7M | $-29.9M | ||
| Q1 24 | $124.8M | $-31.7M |
总资产HNSTRIGL
| Q4 25 | $225.4M | $513.6M | ||
| Q3 25 | $241.5M | $242.5M | ||
| Q2 25 | $249.0M | $206.7M | ||
| Q1 25 | $265.3M | $176.0M | ||
| Q4 24 | $247.4M | $164.0M | ||
| Q3 24 | $209.2M | $139.4M | ||
| Q2 24 | $200.2M | $128.4M | ||
| Q1 24 | $198.1M | $126.5M |
负债/权益比HNSTRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $18.1M | — |
| 自由现金流率自由现金流/营收 | 20.5% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $13.6M | — |
8季度趋势，按日历期对齐
经营现金流HNSTRIGL
| Q4 25 | $19.3M | $22.0M | ||
| Q3 25 | $-504.0K | $24.0M | ||
| Q2 25 | $-745.0K | $30.5M | ||
| Q1 25 | $-2.9M | $-893.0K | ||
| Q4 24 | $-16.8M | $14.5M | ||
| Q3 24 | $15.1M | $21.7M | ||
| Q2 24 | $2.9M | $302.0K | ||
| Q1 24 | $336.0K | $-5.0M |
自由现金流HNSTRIGL
| Q4 25 | $18.1M | — | ||
| Q3 25 | $-624.0K | — | ||
| Q2 25 | $-826.0K | — | ||
| Q1 25 | $-3.0M | — | ||
| Q4 24 | $-17.2M | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $260.0K | — |
自由现金流率HNSTRIGL
| Q4 25 | 20.5% | — | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | -0.9% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | -17.2% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 0.3% | — |
资本支出强度HNSTRIGL
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率HNSTRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.66× | 0.86× | ||
| Q2 25 | -0.19× | 0.51× | ||
| Q1 25 | -0.90× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 91.42× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
